
Baxter International Inc
NYSE:BAX

Intrinsic Value
The intrinsic value of one
BAX
stock under the Base Case scenario is
52.1
USD.
Compared to the current market price of 30.17 USD,
Baxter International Inc
is
Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Baxter International Inc
Fundamental Analysis


Baxter’s recent supply chain disruptions, combined with ongoing product recalls in its infusion pump portfolio, threaten to erode the company’s reputation for quality and could lead to higher costs and reduced revenue growth in the near term.
Baxter’s diversified portfolio—spanning infusion systems, renal care, and advanced surgery products—positions the firm to capture steady growth, as healthcare providers increasingly seek proven, integrated solutions from a single partner.

Revenue & Expenses Breakdown
Baxter International Inc
Balance Sheet Decomposition
Baxter International Inc
Current Assets | 7B |
Cash & Short-Term Investments | 2.3B |
Receivables | 1.7B |
Other Current Assets | 3B |
Non-Current Assets | 14.3B |
PP&E | 3B |
Intangibles | 10.4B |
Other Non-Current Assets | 832m |
Free Cash Flow Analysis
Baxter International Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Baxter International Inc
Revenue
|
11.9B
USD
|
Cost of Revenue
|
-7.5B
USD
|
Gross Profit
|
4.4B
USD
|
Operating Expenses
|
-3.6B
USD
|
Operating Income
|
776m
USD
|
Other Expenses
|
-1.3B
USD
|
Net Income
|
-560m
USD
|
BAX Profitability Score
Profitability Due Diligence
Baxter International Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Score
Baxter International Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
BAX Solvency Score
Solvency Due Diligence
Baxter International Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
Baxter International Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BAX Price Targets Summary
Baxter International Inc
According to Wall Street analysts, the average 1-year price target for
BAX
is 38.36 USD
with a low forecast of 28.28 USD and a high forecast of 54.73 USD.
Dividends
Current shareholder yield for BAX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BAX
stock under the Base Case scenario is
52.1
USD.
Compared to the current market price of 30.17 USD,
Baxter International Inc
is
Undervalued by 42%.